Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Robert Califf Talks Verily, Hopes Gottlieb Can Push Back On Trump

Executive Summary

Former US FDA Commissioner Robert Califf is joining the health-technology firm Verily, a Google spin-off. In a podcast interview with Medtech Insight, he discussed his new advisory role with the company and said he hopes the new FDA Commissioner Scott Gottlieb will be strong in standing up to any "whimsical directives" from President Trump.

You may also be interested in...



US FDA's 'Program Alignment' Inspection Scheme Begins

It was a somewhat muted launch today of the agency's long-awaited "program alignment" facility inspectional approach.

'Program Alignment' Falls Into Place: Everything You Need To Know About US FDA's New Inspectional Approach

For the medical device industry, FDA's five regional offices – Pacific, Central, Northeast, Southwest, Southeast – will be replaced by three distinct divisions across the US encompassing 20 FDA district offices on May 15. Check out the latest US map from the agency showing where the device divisions will be located, and find out what your firm will be facing at its next facility inspection.

FDA Scolds Firms For Claims That Could Mislead The Public About COVID-19 Products

The agency says it has sent letters to dozens of companies that have made ‘FDA Registration Certificate’ claims or used the agency’s logo without authorization, which could lead customers to think the products have been vetted.

Topics

UsernamePublicRestriction

Register

OM008605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel